SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-066597
Filing Date
2021-03-03
Accepted
2021-03-03 07:15:52
Documents
3
Period of Report
2021-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d279770d8k.htm 8-K 18055
2 EX-99.1 d279770dex991.htm EX-99.1 57681
3 GRAPHIC g279770dsp5.jpg GRAPHIC 7215
  Complete submission text file 0001193125-21-066597.txt   86919
Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 21707218
SIC: 2836 Biological Products, (No Diagnostic Substances)